Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease which presently does not have any efficient therapeutic approach. Pimozide, a Food and Drug Administration (FDA)-approved neuroepileptic drug, has been recently proposed as a promising treatment for ALS patients based on appare...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozzi, Silvia, Thammisetty, Sai Sampath, Julien, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095790/
https://www.ncbi.nlm.nih.gov/pubmed/29790082
http://dx.doi.org/10.1007/s13311-018-0634-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095790/
https://www.ncbi.nlm.nih.gov/pubmed/29790082
http://dx.doi.org/10.1007/s13311-018-0634-3

Ejemplares similares